Subprojects:
- Subproject 1: “Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for
cancer treatment (HormOnc)”.
- Subproject 2: “Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal)”.
Original Title (English): Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for
Healing of complex cutaneous wounds (HormHeal).
Objective: Innovating in the healing of complex wounds.
TR2Lab research team members:
- Albert Espona-Noguera (Principal Investigator).
- Cristina Canal (PI1 of Subproject 1) & Francesco Tampieri (PI2 of Subproject 1).
- Elisabet Sarri, Laia Bosch, Gemma Sangüesa, Francesc Sant Masoliver, Cristina Martin Mancera, David Benito Guasch, Clara Masó and Marta Casals.
Funded by: Agencia Estatal de Investigación – Proyectos de generación de conocimiento.
Developed to promote skin regeneration and heal complex wounds, HormHeal combines specialized gel matrices with innovative cold plasma technology and bioactive compounds to speed up self-healing recovery.
Our main goals are focused on 3 key areas:
- Promoting Skin Healing & Patient Care: Restoring damaged skin cells and safely reducing inflammation to shrink wounds, relieve local pain, and improve overall quality of life.
- Boosting Vascular Growth: Stimulating new blood vessel formation and tissue regeneration to efficiently deliver essential nutrients to healing areas.
- Fighting Infections: Eliminating harmful bacteria and persistent biofilms on chronic wounds effectively without relying on conventional antibiotics.
Leave a Reply